04 March 2020.pdf (193KB)
21 Sept 2020.pdf (106KB)
Change Notification 67 2020 - Convalescent Plasma COVID-19 FFP Neonates and infants LD.pdf (493KB)
Change Notification 66 2020 - Convalescent Plasma COVID-19 FFP LD.pdf (434KB)
Change Notification No 64 - Coronavirus Infection WBDSG.pdf (507KB)
Change Notification No 65 - Clinical Trials WBDSG.pdf (468KB)
Change Notification No 64 - Coronavirus Infection WBDSG.pdf (498KB)
Minutes 2 July (Final).pdf (152KB)
Change Notification No 63 - WNV Netherlands - whole country.pdf (487KB)
JPAC Position Statement on Est residual risk of HBV HCV HIV etc - November 2020.pdf (757KB)
JPAC Position Statement on West Nile Virus - November 2020.pdf (536KB)
JPAC Position Statement for Dengue - November 2020.pdf (435KB)
JPAC Position Statement on Zika Virus - November 2020.pdf (354KB)
JPAC Position Statement SARS- CoV-2 COVID-19 - November 2020.pdf (779KB)
Change Notification No 35 2020 - Prov comp WB LD for clinical studies Red Book.pdf (478KB)
Change Notification No 62 - Netherlands (Utrecht) WNV.pdf (518KB)
JPAC Position Statement GDRI - addition and removal of spec country risk - May 2020.pdf (649KB)
JPAC Position Statement on Emerging Infections - May 2020.pdf (402KB)
Change Notification No 44 2020 - South American Trypanosomiasis RISK TDSGs.pdf (469KB)
Change Notification No 61 2020 - Sexually Transmitted Disease All TDSGs.pdf (510KB)